Cargando…

Dexamethasone/tocilizumab: Herpes virus reactivation and COVID-19-associated pulmonary Aspergillosis secondary to off label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062831/ http://dx.doi.org/10.1007/s40278-021-94618-0

Ejemplares similares

Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021)

Dexamethasone: Pulmonary mucormycosis, pulmonary aspergillosis and off-label use: case report
Publicado: (2021)

Dexamethasone: Chronic cavitary pulmonary aspergillosis and off label use: case report
Publicado: (2022)

Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2021)

Tocilizumab: Invasive pulmonary aspergillosis and Escherichia coli infection due to off-label use: case report
Publicado: (2020)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Off-label-use and lack of efficacy: case report
Publicado: (2021)

Tocilizumab: Invasive pulmonary aspergillosis following off-label use of tocilizumab for severe acute respiratory coronavirus-2 infection: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Lack of efficacy during off label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Lack of efficacy following off-label therapy: case report
Publicado: (2022)

Tocilizumab: Herpes zoster infection following an off label use: case report
Publicado: (2022)

Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021)

Dexamethasone: Actinomyces bacteraemia secondary to pseudomembranous necrotising oral-tracheobronchial and invasive pulmonary aspergillosis following off-label use: case report
Publicado: (2022)

Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022)

Dexamethasone: Worsening of Kaposi sarcoma secondary to human herpes virus-8 following off-label use: case report
Publicado: (2021)

Dexamethasone/tocilizumab: Worsening of hepatitis E virus infection following off label use: case report
Publicado: (2022)

Dexamethasone/prednisolone/tocilizumab: Gastrointestinal perforation and off-label use: 3 case reports
Publicado: (2022)

Dexamethasone/tocilizumab: Rhino-orbital mucormycosis following off-label use: 11 case reports
Publicado: (2021)

Dexamethasone/tocilizumab/tofacitinib: Lack of efficacy following off label use: 2 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022)

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19
por: Camon, Ana M., et al.
Publicado: (2022)

Dexamethasone/methylprednisolone: Kaposi's sarcoma secondary to human herpes virus-8 reactivation: case report
Publicado: (2022)

Dexamethasone/tocilizumab: Rhino-orbital cerebral mucormycosis following off-label and overdose: 3 case reports
Publicado: (2022)

Norepinephrine/oseltamivir: Lack of efficacy and invasive pulmonary aspergillosis secondary to off-label use: case report
Publicado: (2020)

Multiple drugs: Off label use, pulmonary aspergillosis and COVID-19 pneumonitis: case report
Publicado: (2021)

Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021)

Corticosteroids/tocilizumab: Reactivation of Mycobacterium tuberculosis following off-label therapy: case report
Publicado: (2020)

Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021)

Anakinra\Convalescent-anti-SARS-CoV-2-plasma\dexamethasone: Pulmonary Aspergillosis and off label use: 6 case reports
Publicado: (2021)

Dexamethasone/hydroxychloroquine: Reactivation of COVID-19 infection and off label use: 4 case reports
Publicado: (2021)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
Publicado: (2020)

PULMONARY ASPERGILLOSIS POST-TOCILIZUMAB TREATMENT IN A PATIENT WITH COVID-19 PNEUMONIA
por: GIDWANI, VIPUL, et al.
Publicado: (2022)

Dexamethasone: Pulmonary mucormycosis following off-label use: case report
Publicado: (2021)

Methylprednisolone/tocilizumab: Herpes Simplex virus type I reactivation and hyperglycaemia: 2 case reports
Publicado: (2021)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/voriconazole: Invasive pulmonary aspergillosis, off label use and lack of efficacy: case report
Publicado: (2021)

Dexamethasone/voriconazole: Invasive pulmonary aspergillosis secondary to Aspergillus terreus and treatment failure: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_69v2s6vtobt55kq10h9vn7afd9